Terry Smith recent buys & sells (2017 Q1)
Fundsmith
Fundsmith Portfolio Changes
Purchase & sale details
- Portfolio value:
- $8.61B~ (+$1B~)
- Previous value:
- $7.59B~
- # of changes:
- 18
- New positions:
- 0
- Reported for:
- 31 Mar 2017 (Q1)
- Latest filing date:
- 05 May 2017
Fundsmith has disclosed a total of 18 changes to the portfolio in the (2017 Q1) SEC report(s): increased the number of shares of 15 and decreased the number of shares of 3 position(s).
What stocks did Terry Smith buy in 2017 Q1?
During 2017 Q1 Terry Smith has bought 15 securities out of which top 5 purchases (by % change to portfolio) were (IDXX) IDEXX Laboratories Inc (added shares +0.07%), (SYK) Stryker Corp (added shares +4.57%), (BCR) CR BARD INC (added shares +2.09%), (PEP) PepsiCo Inc (added shares +7.59%) and (PM) Philip Morris International Inc (added shares +0.17%).
In the 2017 Q1 report(s) the following changes have been made to the top investments: (IDXX) IDEXX Laboratories Inc (added shares +0.07%), (SYK) Stryker Corp (added shares +4.57%), (MSFT) Microsoft Corp (reduced shares -0.00%), (BCR) CR BARD INC (added shares +2.09%) and (PEP) PepsiCo Inc (added shares +7.59%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".